MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, IRWD made $122,060,000 in revenue. $40,080,000 in net income. Net profit margin of 32.84%.

Income Overview

Revenue
$122,060,000
Net Income
$40,080,000
Net Profit Margin
32.84%
EPS
$0.23
Unit: Dollar
Revenue Breakdown
    • Abbvie Plc-Collaborative Arrange...
    • Abbvie Plc-Collaborative Arrange...
    • Astellas Pharma Inc-Collaborativ...
    • Others

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenues
122,060,000 85,239,000 41,143,000 82,711,000
Research and development
22,468,000 23,373,000 27,432,000 25,603,000
Selling, general and administrative
21,908,000 16,795,000 24,260,000 35,597,500
Restructuring, net
2,200,000 -250,000 18,559,000 255,000
Total costs and expenses
46,576,000 39,918,000 70,251,000 61,455,500
Income from operations
75,484,000 45,321,000 -29,108,000 21,255,500
Interest expense and other financing costs
8,434,000 8,356,000 8,070,000 8,072,500
Interest and investment income
930,000 818,000 869,000 973,500
Other
40,000 39,000 37,000 160,000
Other income (expense), net
-7,464,000 -7,499,000 -7,164,000 -6,779,000
Income before income taxes
68,020,000 37,822,000 -36,272,000 14,476,500
Income tax expense
27,940,000 14,223,000 1,114,000 15,429,500
Net income (loss)
----953,000
Net income (loss)
40,080,000 23,599,000 -37,386,000 -953,000
Earnings per share, basic
0.25 0.15 -0.23 0
Earnings per share, diluted
0.23 0.14 -0.23 0
Weighted average number of shares outstanding, basic
162,215,000 161,723,000 160,974,000 -79,818,500
Weighted average number of shares outstanding, diluted
177,764,000 176,837,000 160,974,000 -79,581,000
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Asahi Kasei PharmaCorporation-Collaborative Arrangement...$150,000 Astellas PharmaInc-Collaborative Arrangement...$423,000 AstraZeneca-Collaborative Arrangement...$77,000 AbbviePlc-Collaborative Arrangement...$944,000 AbbviePlc-Collaborative Arrangement...$120,466,000 Total revenues$122,060,000 Income from operations$75,484,000 Total costs andexpenses$46,576,000 Income before incometaxes$68,020,000 Other income(expense), net-$7,464,000 Other$40,000 Interest and investmentincome$930,000 Restructuring, net$2,200,000 Selling, general andadministrative$21,908,000 Research and development$22,468,000 Net income (loss)$40,080,000 Income tax expense$27,940,000 Interest expense andother financing costs$8,434,000

IRONWOOD PHARMACEUTICALS INC (IRWD)

IRONWOOD PHARMACEUTICALS INC (IRWD)